I-Tritylolmesartanethylester CAS:144690-33-5

I-Tritylolmesartanethylester ibaluleke kakhulu kwikhemistri yezonyango kunye nokufunyanwa kwamayeza, ngakumbi ekuphuhlisweni kwee-angiotensin II receptor antagonists ezineeprofayili ze-pharmacological eziphuculweyo. Njengento evela kwi-olmesartan medoxomil, le khompawundi isebenza njengesiseko esibalulekileyo sokwenziwa kunye nokuvavanywa kwee-analog ezintsha ezisebenza kakuhle kunye neempawu ze-pharmacokinetic. Kuphando lwamayeza, i-Tritylolmesartanethylester ifundwa ngenxa yokukwazi kwayo ukuguqula inkqubo ye-renin-angiotensin, edlala indima ebalulekileyo ekulawuleni uxinzelelo lwegazi, ibhalansi yolwelo, kunye nomsebenzi wentliziyo. Ngokuphanda ukusebenzisana kwayo nee-angiotensin II receptors, abaphandi bajolise ekuyileni iikhompawundi ezintsha ezinokuthintela ngempumelelo iziphumo zomzimba ze-angiotensin II, nto leyo ekhokelela ekuphuhlisweni kwamayeza e-antihypertensive esizukulwana esilandelayo aneziphumo zonyango ezingcono kunye neziphumo ebezingalindelekanga ezincitshisiweyo. Ngaphezu koko, utshintsho lwesakhiwo kunye novavanyo lwe-pharmacological lwe-Tritylolmesartanethylester kunye nee-analog zayo zinegalelo ekuqondeni ubudlelwane besakhiwo-umsebenzi (SAR) ngaphakathi kodidi lwe-angiotensin receptor antagonist. Olu lwazi lukhokela uyilo olusengqiqweni lwamayeza afanelekileyo anobuhlobo obuphuculweyo bokubopha ii-receptor, ukukhetha, kunye nokuzinza kwe-metabolic, okuvula indlela yokuqhubela phambili kunyango lwezifo zentliziyo ezifana noxinzelelo lwegazi, ukusilela kwentliziyo, kunye ne-diabetic nephropathy. Ngaphezu koko, ukusetyenziswa okunokwenzeka kweTritylolmesartanethylester kufikelela kwizifundo zangaphambi kweklinikhi ezijolise ekucaciseni iiprofayili zayo ze-pharmacokinetic kunye ne-pharmacodynamic, iiprofayili zetyhefu, kunye nobuchule bonyango ngokusebenzisa uvavanyo lwe-in vitro kunye ne-in vivo. Olu phando lubonelela ngedatha ebalulekileyo yokuvavanya ukhuseleko kunye nokusebenza kwayo, ekugqibeleni ixhasa inkqubela yayo kwizilingo zeklinikhi kunye nophuhliso olunokubakho lwamayeza. Ngamafutshane, ukusetyenziswa kweTritylolmesartanethylester kubandakanya indima yayo ebalulekileyo kwikhemistri yamayeza kunye nophando lwamayeza njengeqonga loyilo, ukuhlanganiswa, kunye novavanyo lwee-angiotensin II receptor antagonists ezintsha, ezinegalelo ekuphuculeni unyango lwe-antihypertensive kunye ne-cardiovascular pharmacology.